Showing results (901-910 of 8,092) with videos related to
Sort By:
Pageof 810
Clinical and Experimental Rheumatology|June 8, 2002
Renal tolerability of three commonly employed non-steroidal anti-inflammatory drugs in elderly patients with osteoarthritisL Niccoli, S Bellino, F CantiniClinical and Experimental Rheumatology|June 8, 2002
Anthrax vaccination and joint related adverse reactions in light of biological warfare scenariosD A Geier, M R GeierClinical and Experimental Rheumatology|June 8, 2002
The association of serum matrix metalloproteinases and their tissue inhibitor levels with scleroderma disease severityE Toubi, A Kessel, G Grushko, et al.Clinical and Experimental Rheumatology|June 8, 2002
Involvement of the thoracic spine in tophaceous gout. A case reportA W S Souza, S Fontenele, H Carrete, et al.Clinical and Experimental Rheumatology|April 4, 2003
Interleukin-10 receptor expression in systemic lupus erythematosus and rheumatoid arthritisA P Cairns, A D Crockard, A L BellClinical and Experimental Rheumatology|April 4, 2003
Scleroderma renal crisis in pregnancy associated with massive proteinuriaA N Brown, M B BolsterClinical and Experimental Rheumatology|April 4, 2003
Allergic diseases in systemic lupus erythematosus: prevalence and immunological considerationsI Sekigawa, T Yoshiike, N Iida, et al.Clinical and Experimental Rheumatology|July 10, 2002
Methodological update detection of antibodies to dsDNA: current insights into its relevanceR J T SmeenkClinical and Experimental Rheumatology|July 10, 2002
Confidence in the diagnosis of early spondylarthropathy: a prospective follow-up of 270 early arthritis patientsJ M Berthelot, A Saraux, C Le Henaff, et al.Clinical and Experimental Rheumatology|July 10, 2002
Treating rheumatoid arthritis early with disease modifying drugs reduces joint damage: a randomised double blind trial of sulphasalazine vs diclofenac sodiumE H S Choy, D L Scott, G H Kingsley, et al.Pageof 810